These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30865322)

  • 1. Evaluation of a low-dose desoxycorticosterone pivalate treatment protocol for long-term management of dogs with primary hypoadrenocorticism.
    Sieber-Ruckstuhl NS; Reusch CE; Hofer-Inteeworn N; Kuemmerle-Fraune C; Müller C; Hofmann-Lehmann R; Boretti FS
    J Vet Intern Med; 2019 May; 33(3):1266-1271. PubMed ID: 30865322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of primary hypoadrenocorticism in dogs with low dose desoxycorticosterone pivalate].
    Münch L; Münch M; Paul H; Miklis A; Heinrich M; Neiger R
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2020 Jun; 48(3):171-175. PubMed ID: 32557492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desoxycorticosterone Pivalate Duration of Action and Individualized Dosing Intervals in Dogs with Primary Hypoadrenocorticism.
    Jaffey JA; Nurre P; Cannon AB; DeClue AE
    J Vet Intern Med; 2017 Nov; 31(6):1649-1657. PubMed ID: 28892205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of plasma renin activity to monitor mineralocorticoid treatment in dogs with primary hypoadrenocorticism: desoxycorticosterone versus fludrocortisone.
    Baumstark ME; Nussberger J; Boretti FS; Baumstark MW; Riond B; Reusch CE; Sieber-Ruckstuhl NS
    J Vet Intern Med; 2014; 28(5):1471-8. PubMed ID: 25274440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower initial dose desoxycorticosterone pivalate for treatment of canine primary hypoadrenocorticism.
    Bates JA; Shott S; Schall WD
    Aust Vet J; 2013 Mar; 91(3):77-82; discussion 81-2. PubMed ID: 23438457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and long-term follow-up of 205 dogs with hypoadrenocorticism.
    Kintzer PP; Peterson ME
    J Vet Intern Med; 1997; 11(2):43-9. PubMed ID: 9127289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desoxycorticosterone pivalate in the management of canine primary hypoadrenocorticism.
    Van Zyl M; Hyman WB
    J S Afr Vet Assoc; 1994 Sep; 65(3):125-9. PubMed ID: 7595920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous administration of desoxycorticosterone pivalate for the treatment of canine hypoadrenocorticism.
    McCabe MD; Feldman EC; Lynn RC; Kass PH
    J Am Anim Hosp Assoc; 1995; 31(2):151-5. PubMed ID: 7773761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose desoxycorticosterone pivalate treatment of hypoadrenocorticism in dogs: A randomized controlled clinical trial.
    Vincent AM; Okonkowski LK; Brudvig JM; Refsal KR; Berghoff N; Olivier NB; Langlois DK
    J Vet Intern Med; 2021 Jul; 35(4):1720-1728. PubMed ID: 34114259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and long-term management of cats with primary hypoadrenocorticism using desoxycorticosterone pivalate and prednisolone.
    Sieber-Ruckstuhl NS; Harburger L; Hofer N; Kümmerle C; Müller C; Riond B; Hofmann-Lehmann R; Reusch CE; Boretti FS
    J Vet Intern Med; 2023 Mar; 37(2):420-427. PubMed ID: 36809682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of microcrystalline desoxycorticosterone pivalate for treatment of hypoadrenocorticism in dogs. DOCP Clinical Study Group.
    Lynn RC; Feldman EC; Nelson RW
    J Am Vet Med Assoc; 1993 Feb; 202(3):392-6. PubMed ID: 8440628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of desoxycorticosterone pivalate administration on blood pressure in dogs with primary hypoadrenocorticism.
    Kaplan AJ; Peterson ME
    J Am Vet Med Assoc; 1995 Feb; 206(3):327-31. PubMed ID: 7751240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of a cat with primary hypoadrenocorticism and severe hyponatremia with desoxycorticosterone pivalate (DOCP).
    Woolcock AD; Ward C
    Can Vet J; 2015 Nov; 56(11):1158-60. PubMed ID: 26538671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine electrolytes do not predict desoxycorticosterone pivalate efficacy in dogs with hypoadrenocorticism.
    Langlois DK; Dropkin CA; Kruger JM
    Am J Vet Res; 2023 Aug; 84(8):. PubMed ID: 37279885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of canine hypoadrenocorticism with microcrystalline desoxycorticosterone pivalate.
    Lynn RC; Feldman EC
    Br Vet J; 1991; 147(5):478-83. PubMed ID: 1959020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised clinical non-inferiority trial comparing two formulations of desoxycortone pivalate for the treatment of canine primary hypoadrenocorticism.
    Farr H; Mason BL; Longhofer SL
    Vet Rec; 2020 Jul; 187(2):e12. PubMed ID: 31974265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of symmetric dimethylarginine and creatinine in dogs with primary hypoadrenocorticism receiving long-term mineralocorticoid replacement therapy.
    Casado Díaz JI; Sieber-Ruckstuhl NS; Boretti FS; Fracassi F; Reusch CE
    Vet Rec; 2022 Jan; 190(1):e242. PubMed ID: 33870518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Serum Thyrotropin Concentrations in Dogs with Primary Hypoadrenocorticism before and during Treatment.
    Reusch CE; Fracassi F; Sieber-Ruckstuhl NS; Burkhardt WA; Hofer-Inteeworn N; Schuppisser C; Stirn M; Hofmann-Lehmann R; Boretti FS
    J Vet Intern Med; 2017 Nov; 31(6):1643-1648. PubMed ID: 29024024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized vitiligo in a dog with primary hypoadrenocorticism.
    Malerba E; Morini M; Fracassi F
    Vet Dermatol; 2015 Oct; 26(5):376-8, e86. PubMed ID: 26104920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of naturally occurring hypoadrenocorticism in 42 dogs.
    Melián C; Peterson ME
    J Small Anim Pract; 1996 Jun; 37(6):268-75. PubMed ID: 8805097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.